NovoCure NVCR
NASDAQ NVCR
$14.94 -0.98 (-6.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

NovoCure (NVCR) Cash & Current Investments (2014 - 2026)

Updated

NovoCure (NVCR) posted Cash & Current Investments of $440.56 million for Q2 2026, down 51.7% from $911.53 million a year earlier but up 2.0% from the prior quarter.

Analysis

NovoCure (NVCR) Cash & Current Investments (2014 - 2026) Analysis & Trends

At the end of FY2025, NovoCure's Cash & Current Investments came in at $447.67 million, down 53.4% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of -11.9% (FY2020 to FY2025).
  • In prior years, NovoCure's Cash & Current Investments was $959.87 million in FY2024 (+5.4%), $910.62 million in FY2023 (-6.1%), $969.43 million in FY2022 (+3.4%) and $937.7 million in FY2021 (+11.3%).
  • Quarterly Cash & Current Investments has run from a low of $432 million in Q1 2026 to a high of $1.03 billion in Q3 2025 over five years.
  • On a year-over-year basis, Cash & Current Investments has declined in each of the last three quarters, with an average decline of 17.3% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2021, with growth of 298.3%; the weakest was Q1 2026, with a decline of 53.5%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $432 million (Q1 2026), $447.67 million (Q4 2025) and $1.03 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 4.06 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 5.60 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 4.35 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 5.22 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 8.82 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 3.48 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 539.00 Mn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 4.25 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 709.00 Mn
10 NovoCure 1.74 Bn -614.09 Mn 142.48 Mn 440.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 440.56 Mn
Mar 31, 2026 432.00 Mn
Dec 31, 2025 447.67 Mn
Sep 30, 2025 1.03 Bn
Jun 30, 2025 911.53 Mn
Mar 31, 2025 929.13 Mn
Dec 31, 2024 959.87 Mn
Sep 30, 2024 959.90 Mn
Jun 30, 2024 951.19 Mn
Mar 31, 2024 870.15 Mn
Dec 31, 2023 910.62 Mn
Sep 30, 2023 921.25 Mn
Jun 30, 2023 940.82 Mn
Mar 31, 2023 958.04 Mn
Dec 31, 2022 969.43 Mn
Sep 30, 2022 970.32 Mn
Jun 30, 2022 948.52 Mn
Mar 31, 2022 932.30 Mn
Dec 31, 2021 937.70 Mn
Sep 30, 2021 933.79 Mn
API Access

NovoCure Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NVCR&period=max&api_key=YOUR_API_KEY